Washington [US], June 25 (ANI): Early in the COVID-19 pandemic, scientists identified how SARS-CoV-2, the virus that causes COVID-19, gets inside cells to cause infection. All current COVID-19 vaccines and antibody-based therapeutics were designed to disrupt this route into cells, which requ
Moscow [Russia], June 15 (ANI/Sputnik): AstraZeneca announced on Tuesday that the clinical trial of its long-acting antibody cocktail has not provided evidence of effectiveness in protecting people exposed to the coronavirus.
New Delhi [India], June 15 (ANI): The Union Health Ministry on Tuesday revealed that the Delta variant with an additional mutation known as "Delta Plus" has been detected in the country that nullifies the use of monoclonal antibody but asserted that it still not a "variant of concern".
New Delhi [India], June 14 (ANI): Apollo Hospitals Managing Director Dr Sangeeta Reddy on Monday said that the antibody cocktail Regeneron treatment she took after contracting Covid-19 made a dramatic difference in her recovery from the infection.
Chennai (Tamil Nadu) [India], June 9 (ANI/NewsVoir): Kauvery Hospitals, one of the leading healthcare chains in Tamil Nadu, successfully performed a kidney transplant on a 35-year-old woman who recovered from COVID-19 infection recently. The patient from Madurai, came to Chennai for effectiv
New Delhi [India], June 9 (ANI): Sir Ganga Ram Hospital of New Delhi has reported successful use of Monoclonal antibody in two patients with fast progression of symptoms within the first seven days. Both patients recovered and were discharged with 12 hours.
New Delhi [India], June 7 (ANI): Test results of an 18-year-old boy who recently suffered cardiac failure revealed a high antibody count in his body and confirmed, what doctors have all along suspected, that coronavirus disease can directly affect the heart and cause a potential life thre
New Delhi [India], June 7 (ANI): Covishield vaccine produced more antibodies than Covaxin, according to a preliminary study by Coronavirus Vaccine-induced Antibody Titre (COVAT) involving healthcare workers (HCW) who have received both doses of either of the two vaccines.
New Delhi [India], June 6 (ANI): The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" patients who are Covid positive is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) free of cost.
New Delhi [India], June 3 (ANI): A Delhi Hospital on Tuesday pulled two high-risk senior citizen COVID-19 patients out of danger by administering Monoclonal Antibody Cocktail (MAC) therapy.
New Delhi [India], June 1 (ANI): Delhi's Sir Gangaram Hospital on Tuesday commenced administration of Monoclonal Antibody Cocktail (MAC) to coronavirus patients, the medical facility said in a statement.
New Delhi [India], June 1 (ANI): Eli Lilly and Company India on Tuesday announced that it has received emergency use approval in the country for its monoclonal antibody drug combination used for treating Covid-19 patients with mild to moderate symptoms.